OCULAR HYPERTENSION
Clinical trials for OCULAR HYPERTENSION explained in plain language.
Never miss a new study
Get alerted when new OCULAR HYPERTENSION trials appear
Sign up with your email to follow new studies for OCULAR HYPERTENSION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New eye drops show promise for glaucoma patients
Disease control CompletedThis study tested a new eye drop called SBI-100 in 56 adults with glaucoma or high eye pressure. Participants used the drops twice daily for 14 days. Researchers measured how well the drops lowered eye pressure and checked for side effects. The goal was to see if SBI-100 is safe …
Matched conditions: OCULAR HYPERTENSION
Phase: PHASE2 • Sponsor: Skye Bioscience, Inc. • Aim: Disease control
Last updated May 17, 2026 05:45 UTC
-
New eye drop shows promise in glaucoma battle
Disease control CompletedThis study tested two different strengths of a new eye drop, T4090, against an existing drop called Rhopressa in 161 adults with open-angle glaucoma or high eye pressure. The goal was to see which one lowers eye pressure better and is safer. Both treatments aim to control the dis…
Matched conditions: OCULAR HYPERTENSION
Phase: PHASE2 • Sponsor: Laboratoires Thea • Aim: Disease control
Last updated May 17, 2026 05:32 UTC
-
New eye drops show promise for glaucoma patients
Disease control CompletedThis study tested two new eye drops (AR-17043 and a combination with latanoprost) to see if they safely lower eye pressure in people with open-angle glaucoma or high eye pressure. A total of 426 adults took part. The goal was to find the best dose for reducing pressure, which is …
Matched conditions: OCULAR HYPERTENSION
Phase: PHASE2 • Sponsor: Alcon Research • Aim: Disease control
Last updated May 17, 2026 05:31 UTC
-
New implant tackles cataracts and glaucoma in one surgery
Disease control CompletedThis study tested a device that combines a cataract lens with a slow-release glaucoma medication. 24 adults with cataracts and high eye pressure or mild-to-moderate glaucoma received the implant during standard cataract surgery. The goal was to see if it safely lowers eye pressur…
Matched conditions: OCULAR HYPERTENSION
Phase: NA • Sponsor: SpyGlass Pharma, Inc. • Aim: Disease control
Last updated May 15, 2026 11:55 UTC
-
New eye drop shows promise for glaucoma patients
Disease control CompletedThis study tested a new eye drop called Reformulated PG324 to see how safe and effective it is at lowering eye pressure in people with open-angle glaucoma or ocular hypertension. About 489 participants took part. The goal is to help control the disease and prevent vision loss, bu…
Matched conditions: OCULAR HYPERTENSION
Phase: PHASE3 • Sponsor: Alcon Research • Aim: Disease control
Last updated May 11, 2026 20:40 UTC
-
New eye drop shows promise in lowering glaucoma pressure
Disease control CompletedThis study tested a new eye drop, NCX 470, against a standard treatment (latanoprost) in 696 people with open-angle glaucoma or high eye pressure. Participants used the drops once daily for up to 12 months. The main goal was to see how well NCX 470 lowers eye pressure compared to…
Matched conditions: OCULAR HYPERTENSION
Phase: PHASE3 • Sponsor: Nicox Ophthalmics, Inc. • Aim: Disease control
Last updated May 06, 2026 16:15 UTC
-
Smart contact lens could revolutionize glaucoma monitoring
Diagnosis CompletedThis study tested a new contact lens device that records eye pressure patterns over 24 hours in 86 adults with glaucoma and healthy volunteers. Participants wore the lens in one eye and took smartphone pictures every 15 minutes while awake. Researchers compared the lens readings …
Matched conditions: OCULAR HYPERTENSION
Sponsor: Smartlens, Inc. • Aim: Diagnosis
Last updated May 15, 2026 11:54 UTC